Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Altesa has raised $75.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
Altesa's investors include Atlantic Partners, Sanofi, Pitango VC, Medicxi, Forbion Capital Partners.
Altesa is headquartered in College Park, United States.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
Altesa is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Altesa — Funding & Investors." VCBacked, February 19, 2026, https://www.vcbacked.co/company/altesa. Accessed September 30, 2026.
VCBacked. (2026). Altesa — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/altesa
{{cite web |title=Altesa — Funding & Investors |url=https://www.vcbacked.co/company/altesa |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated